메뉴 건너뛰기




Volumn 17, Issue 2, 2015, Pages 123-134

Advancements in the development of subunit influenza vaccines

Author keywords

Hemagglutinin; Influenza A virus; Matrix protein; Nucleoprotein; Subunit vaccines

Indexed keywords

HEMAGGLUTININ; INFLUENZA VACCINE; MATRIX PROTEIN; NUCLEOPROTEIN; SUBUNIT VACCINE;

EID: 84921496495     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2014.12.006     Document Type: Article
Times cited : (47)

References (121)
  • 2
    • 84921465892 scopus 로고    scopus 로고
    • Evolutionary dynamics of highly pathogenic avian influenza A/H5N1 HA clades and vaccine implementation in Vietnam
    • Le T.H., Nguyen N.T. Evolutionary dynamics of highly pathogenic avian influenza A/H5N1 HA clades and vaccine implementation in Vietnam. Clin Exp Vaccine Res 2014, 3:117-127.
    • (2014) Clin Exp Vaccine Res , vol.3 , pp. 117-127
    • Le, T.H.1    Nguyen, N.T.2
  • 3
    • 0344395604 scopus 로고    scopus 로고
    • Are we ready for pandemic influenza?
    • Webby R.J., Webster R.G. Are we ready for pandemic influenza?. Science 2003, 302:1519-1522.
    • (2003) Science , vol.302 , pp. 1519-1522
    • Webby, R.J.1    Webster, R.G.2
  • 4
    • 84877785371 scopus 로고    scopus 로고
    • Human infection with a novel avian-origin influenza A (H7N9) virus
    • Gao R., Cao B., Hu Y., Feng Z., Wang D., Hu W., et al. Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med 2013, 368:1888-1897.
    • (2013) N Engl J Med , vol.368 , pp. 1888-1897
    • Gao, R.1    Cao, B.2    Hu, Y.3    Feng, Z.4    Wang, D.5    Hu, W.6
  • 5
    • 0033602713 scopus 로고    scopus 로고
    • Role of hemagglutinin cleavage for the pathogenicity of influenza virus
    • Steinhauer D.A. Role of hemagglutinin cleavage for the pathogenicity of influenza virus. Virology 1999, 258:1-20.
    • (1999) Virology , vol.258 , pp. 1-20
    • Steinhauer, D.A.1
  • 6
    • 74049096170 scopus 로고    scopus 로고
    • Influenza A: understanding the viral life cycle
    • Samji T. Influenza A: understanding the viral life cycle. Yale J Bio Med 2009, 82:153-159.
    • (2009) Yale J Bio Med , vol.82 , pp. 153-159
    • Samji, T.1
  • 7
    • 9644283009 scopus 로고    scopus 로고
    • Assembly and budding of influenza virus
    • Nayak D.P., Hui E., Barman S. Assembly and budding of influenza virus. Virus Res 2004, 106:147-165.
    • (2004) Virus Res , vol.106 , pp. 147-165
    • Nayak, D.P.1    Hui, E.2    Barman, S.3
  • 9
    • 0032472328 scopus 로고    scopus 로고
    • The influenza virus NEP (NS2 protein) mediates the nuclear export of viral ribonucleoproteins
    • O'Neill R.E., Talon J., Palese P. The influenza virus NEP (NS2 protein) mediates the nuclear export of viral ribonucleoproteins. EMBO J 1998, 17:288-296.
    • (1998) EMBO J , vol.17 , pp. 288-296
    • O'Neill, R.E.1    Talon, J.2    Palese, P.3
  • 10
    • 33644841402 scopus 로고    scopus 로고
    • Influenza virus virulence and its molecular determinants
    • Noah D.L., Krug R.M. Influenza virus virulence and its molecular determinants. Adv Virus Res 2005, 65:121-145.
    • (2005) Adv Virus Res , vol.65 , pp. 121-145
    • Noah, D.L.1    Krug, R.M.2
  • 11
    • 0037443870 scopus 로고    scopus 로고
    • Activation of influenza virus RNA polymerase by the 5' and 3' terminal duplex of genomic RNA
    • Lee M.T.M., Klumpp K., Digard P., Tiley L. Activation of influenza virus RNA polymerase by the 5' and 3' terminal duplex of genomic RNA. Nucleic Acids Res 2003, 31:1624-1632.
    • (2003) Nucleic Acids Res , vol.31 , pp. 1624-1632
    • Lee, M.T.M.1    Klumpp, K.2    Digard, P.3    Tiley, L.4
  • 12
    • 0037402154 scopus 로고    scopus 로고
    • The epidemiology and clinical impact of pandemic influenza
    • Nguyen-Van-Tam J.S., Hampson A.W. The epidemiology and clinical impact of pandemic influenza. Vaccine 2003, 21:1762-1768.
    • (2003) Vaccine , vol.21 , pp. 1762-1768
    • Nguyen-Van-Tam, J.S.1    Hampson, A.W.2
  • 13
    • 31344482504 scopus 로고    scopus 로고
    • 1918 Influenza: the mother of all pandemics
    • Taubenberger J.K., Morens D.M. 1918 Influenza: the mother of all pandemics. Emerg Infect Dis 2006, 12:15-22.
    • (2006) Emerg Infect Dis , vol.12 , pp. 15-22
    • Taubenberger, J.K.1    Morens, D.M.2
  • 16
    • 0141566293 scopus 로고    scopus 로고
    • Relationship of pre-1918 avian influenza HA and NP sequences to subsequent avian influenza strains
    • Reid A., Fanning T., Slemons R., Janczewski T., Dean J., Taubenberger J. Relationship of pre-1918 avian influenza HA and NP sequences to subsequent avian influenza strains. Avian Dis 2003, 47:921-925.
    • (2003) Avian Dis , vol.47 , pp. 921-925
    • Reid, A.1    Fanning, T.2    Slemons, R.3    Janczewski, T.4    Dean, J.5    Taubenberger, J.6
  • 17
    • 0018144758 scopus 로고
    • On the origin of thehuman influenza virus subtypes H2N2 and H3N2
    • Scholtissek C., Rohde W., Von Hoyningen V., Rott R. On the origin of thehuman influenza virus subtypes H2N2 and H3N2. Virology 1978, 87:13-20.
    • (1978) Virology , vol.87 , pp. 13-20
    • Scholtissek, C.1    Rohde, W.2    Von Hoyningen, V.3    Rott, R.4
  • 18
    • 0024439330 scopus 로고
    • Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics
    • Kawaoka Y., Krauss S., Webster R.G. Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics. J Virol 1989, 63:4603-4608.
    • (1989) J Virol , vol.63 , pp. 4603-4608
    • Kawaoka, Y.1    Krauss, S.2    Webster, R.G.3
  • 19
  • 20
    • 0030850759 scopus 로고    scopus 로고
    • Perspectives on pandemics: a research agenda
    • Kilbourne E.D. Perspectives on pandemics: a research agenda. J Infec Dis 1997, 176:S29-S31.
    • (1997) J Infec Dis , vol.176 , pp. S29-S31
    • Kilbourne, E.D.1
  • 21
    • 67649297821 scopus 로고    scopus 로고
    • Emergence and pandemic potential of swine-origin H1N1 influenza virus
    • Neumann G., Noda T., Kawaoka Y. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 2009, 459:931-939.
    • (2009) Nature , vol.459 , pp. 931-939
    • Neumann, G.1    Noda, T.2    Kawaoka, Y.3
  • 22
    • 67650407532 scopus 로고    scopus 로고
    • Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans
    • Garten R.J., Davis C.T., Russell C.A., Shu B., Lindstrom S., Balish A., et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009, 325:197-201.
    • (2009) Science , vol.325 , pp. 197-201
    • Garten, R.J.1    Davis, C.T.2    Russell, C.A.3    Shu, B.4    Lindstrom, S.5    Balish, A.6
  • 23
    • 66149093121 scopus 로고    scopus 로고
    • Different evolutionary trajectories of European avian-like and classical swine H1N1 influenza A viruses
    • Dunham E.J., Dugan V.G., Kaser E.K., Perkins S.E., Brown I.H., Holmes E.C., et al. Different evolutionary trajectories of European avian-like and classical swine H1N1 influenza A viruses. J Virol 2009, 83:5485-5494.
    • (2009) J Virol , vol.83 , pp. 5485-5494
    • Dunham, E.J.1    Dugan, V.G.2    Kaser, E.K.3    Perkins, S.E.4    Brown, I.H.5    Holmes, E.C.6
  • 24
    • 67650892251 scopus 로고    scopus 로고
    • The persistent legacy of the 1918 influenza virus
    • Morens D.M., Taubenberger J.K., Fauci A.S. The persistent legacy of the 1918 influenza virus. N Engl J Med 2009, 361:225-229.
    • (2009) N Engl J Med , vol.361 , pp. 225-229
    • Morens, D.M.1    Taubenberger, J.K.2    Fauci, A.S.3
  • 25
    • 0344118228 scopus 로고    scopus 로고
    • Genetic reassortment of avian, swine, and human influenza A viruses in American pigs
    • Zhou N.N., Senne D.A., Landgraf J.S., Swenson S.L., Erickson G., Rossow K., et al. Genetic reassortment of avian, swine, and human influenza A viruses in American pigs. J Virol 1999, 73:8851-8856.
    • (1999) J Virol , vol.73 , pp. 8851-8856
    • Zhou, N.N.1    Senne, D.A.2    Landgraf, J.S.3    Swenson, S.L.4    Erickson, G.5    Rossow, K.6
  • 26
    • 0037053093 scopus 로고    scopus 로고
    • The emergence of novel swine influenza viruses in North America
    • Olsen C.W. The emergence of novel swine influenza viruses in North America. Virus Res 2002, 85:199-210.
    • (2002) Virus Res , vol.85 , pp. 199-210
    • Olsen, C.W.1
  • 27
    • 0019417811 scopus 로고
    • Evidence for the natural transmission of influenza A virus from wild ducts to swine and its potential importance for man
    • Pensaert M., Ottis K., Vandeputte J., Kaplan M.M., Bachmann P.A. Evidence for the natural transmission of influenza A virus from wild ducts to swine and its potential importance for man. Bull World Health Organ 1981, 59:75-78.
    • (1981) Bull World Health Organ , vol.59 , pp. 75-78
    • Pensaert, M.1    Ottis, K.2    Vandeputte, J.3    Kaplan, M.M.4    Bachmann, P.A.5
  • 29
    • 0033567144 scopus 로고    scopus 로고
    • Genetic characterization of the pathogenic influenza A/Goose/Guangdong/1/96 (H5N1) virus: similarity of its hemagglutinin gene to those of H5N1 viruses from the 1997 outbreaks in Hong Kong
    • Xu X., Subbarao K., Cox N.J., Guo Y. Genetic characterization of the pathogenic influenza A/Goose/Guangdong/1/96 (H5N1) virus: similarity of its hemagglutinin gene to those of H5N1 viruses from the 1997 outbreaks in Hong Kong. Virology 1999, 261:15-19.
    • (1999) Virology , vol.261 , pp. 15-19
    • Xu, X.1    Subbarao, K.2    Cox, N.J.3    Guo, Y.4
  • 30
    • 0034965278 scopus 로고    scopus 로고
    • Efficacy of vaccines in chickens against highly pathogenic Hong Kong H5N1 avian influenza
    • Swayne D.E., Beck J.R., Perdue M.L., Beard C.W. Efficacy of vaccines in chickens against highly pathogenic Hong Kong H5N1 avian influenza. Avian Dis 2001, 355-365.
    • (2001) Avian Dis , pp. 355-365
    • Swayne, D.E.1    Beck, J.R.2    Perdue, M.L.3    Beard, C.W.4
  • 31
    • 80052842317 scopus 로고    scopus 로고
    • Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009-2010
    • Meijer A., Jonges M., Abbink F., Ang W., van Beek J., Beersma M., et al. Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009-2010. Antivir Res 2011, 92:81-89.
    • (2011) Antivir Res , vol.92 , pp. 81-89
    • Meijer, A.1    Jonges, M.2    Abbink, F.3    Ang, W.4    van Beek, J.5    Beersma, M.6
  • 33
    • 71849086651 scopus 로고    scopus 로고
    • Oseltamivir resistance and the H274Y neuraminidase mutation in seasonal, pandemic and highly pathogenic influenza viruses
    • Hurt A.C., Holien J.K., Parker M.W., Barr I.G. Oseltamivir resistance and the H274Y neuraminidase mutation in seasonal, pandemic and highly pathogenic influenza viruses. Drugs 2009, 69:2523-2531.
    • (2009) Drugs , vol.69 , pp. 2523-2531
    • Hurt, A.C.1    Holien, J.K.2    Parker, M.W.3    Barr, I.G.4
  • 34
    • 0015424394 scopus 로고
    • Isolation and properties of amantadine-resistant variants of influenza A virus
    • Lavrov S.V., Podchernyayeva R.Y., Blinova V.K., Sokolov M.I. Isolation and properties of amantadine-resistant variants of influenza A virus. Acta Virol 1972, 16:507.
    • (1972) Acta Virol , vol.16 , pp. 507
    • Lavrov, S.V.1    Podchernyayeva, R.Y.2    Blinova, V.K.3    Sokolov, M.I.4
  • 35
    • 77953643549 scopus 로고    scopus 로고
    • Adamantane resistance in seasonal human influenza A viruses from Calgary, Alberta (January 2007 to August 2008)
    • Pabbaraju K., Wong S., Kits D.K., Fox J.D. Adamantane resistance in seasonal human influenza A viruses from Calgary, Alberta (January 2007 to August 2008). Can J Infect Dis Med Microbiol 2010, 21:e87-91.
    • (2010) Can J Infect Dis Med Microbiol , vol.21 , pp. e87-91
    • Pabbaraju, K.1    Wong, S.2    Kits, D.K.3    Fox, J.D.4
  • 36
  • 38
    • 84908459107 scopus 로고    scopus 로고
    • Efficacy of live attenuated influenza vaccine against influenza illness in children as a function of illness severity
    • Ambrose C.S., Wu X., Caspard H., Belshe R.B. Efficacy of live attenuated influenza vaccine against influenza illness in children as a function of illness severity. Vaccine 2014, 32:5546-5548.
    • (2014) Vaccine , vol.32 , pp. 5546-5548
    • Ambrose, C.S.1    Wu, X.2    Caspard, H.3    Belshe, R.B.4
  • 39
    • 84908577676 scopus 로고    scopus 로고
    • Pulmonary immunization of chickens using non-adjuvanted spray-freeze dried whole inactivated virus vaccine completely protects against highly pathogenic H5N1 avian influenza virus
    • Peeters B., Tonnis W.F., Murugappan S., Rottier P., Koch G., Frijlink H.W., et al. Pulmonary immunization of chickens using non-adjuvanted spray-freeze dried whole inactivated virus vaccine completely protects against highly pathogenic H5N1 avian influenza virus. Vaccine 2014, pii: S0264-410X(14)01316-4.
    • (2014) Vaccine
    • Peeters, B.1    Tonnis, W.F.2    Murugappan, S.3    Rottier, P.4    Koch, G.5    Frijlink, H.W.6
  • 40
    • 77950650685 scopus 로고    scopus 로고
    • Attenuated influenza virus vaccines withmodified NS1 proteins
    • Richt J.A., García-Sastre A. Attenuated influenza virus vaccines withmodified NS1 proteins. Curr Top Microbiol Immunol 2009, 333:177-195.
    • (2009) Curr Top Microbiol Immunol , vol.333 , pp. 177-195
    • Richt, J.A.1    García-Sastre, A.2
  • 41
    • 84922327417 scopus 로고    scopus 로고
    • Intranasal seasonal influenza vaccine and a TLR-3 agonist, rintatolimod, induced cross-reactive IgA antibody formation against avian H5N1 and H7N9 influenza HA in humans
    • Overton E.T., Goepfert P.A., Cunningham P., Carter W.A., Horvath J., Young D., et al. Intranasal seasonal influenza vaccine and a TLR-3 agonist, rintatolimod, induced cross-reactive IgA antibody formation against avian H5N1 and H7N9 influenza HA in humans. Vaccine 2014, 32:5490-5495.
    • (2014) Vaccine , vol.32 , pp. 5490-5495
    • Overton, E.T.1    Goepfert, P.A.2    Cunningham, P.3    Carter, W.A.4    Horvath, J.5    Young, D.6
  • 42
    • 84876328535 scopus 로고    scopus 로고
    • Influenza viruses with rearranged genomes as live-attenuated vaccines
    • Pena L., Sutton T., Chockalingam A., Kumar S., Angel M., Shao H., et al. Influenza viruses with rearranged genomes as live-attenuated vaccines. J Virol 2013, 87:5118-5127.
    • (2013) J Virol , vol.87 , pp. 5118-5127
    • Pena, L.1    Sutton, T.2    Chockalingam, A.3    Kumar, S.4    Angel, M.5    Shao, H.6
  • 43
    • 0025833818 scopus 로고
    • Regulatory philosophy and acceptability of cells for the production of biologicals
    • Petricciani J.C. Regulatory philosophy and acceptability of cells for the production of biologicals. Dev Biol Stand 1991, 75:9-15.
    • (1991) Dev Biol Stand , vol.75 , pp. 9-15
    • Petricciani, J.C.1
  • 44
  • 45
    • 84897044592 scopus 로고    scopus 로고
    • Comparative analysis of antibody induction and protection against influenza virus infection by DNA immunization with HA, HAe, and HA1 in mice
    • Chen J., Liu Q., Chen Q., Xiong C., Yao Y., Wang H., et al. Comparative analysis of antibody induction and protection against influenza virus infection by DNA immunization with HA, HAe, and HA1 in mice. Arch Virol 2014, 159:689-700.
    • (2014) Arch Virol , vol.159 , pp. 689-700
    • Chen, J.1    Liu, Q.2    Chen, Q.3    Xiong, C.4    Yao, Y.5    Wang, H.6
  • 46
    • 79951785009 scopus 로고    scopus 로고
    • Broad humoral and cellular immunity elicited by a bivalent DNA vaccine encoding HA and NP genes from an H5N1 virus
    • Xu K., Ling Z.Y., Sun L., Xu Y., Bian C., He Y., et al. Broad humoral and cellular immunity elicited by a bivalent DNA vaccine encoding HA and NP genes from an H5N1 virus. Viral Immunol 2011, 24:45-56.
    • (2011) Viral Immunol , vol.24 , pp. 45-56
    • Xu, K.1    Ling, Z.Y.2    Sun, L.3    Xu, Y.4    Bian, C.5    He, Y.6
  • 47
    • 0030893680 scopus 로고    scopus 로고
    • Cross-protection among lethal H5N2 influenza viruses induced by DNA vaccine to the hemagglutinin
    • Kodihalli S., Haynes J.R., Robinson H.L., Webster R.G. Cross-protection among lethal H5N2 influenza viruses induced by DNA vaccine to the hemagglutinin. J Virol 1997, 71:3391-3396.
    • (1997) J Virol , vol.71 , pp. 3391-3396
    • Kodihalli, S.1    Haynes, J.R.2    Robinson, H.L.3    Webster, R.G.4
  • 48
    • 0033055999 scopus 로고    scopus 로고
    • DNA vaccine encoding hemagglutinin provides protective immunity against H5N1 influenza virus infection in mice
    • Kodihalli S., Goto H., Kobasa D.L., Krauss S., Kawaoka Y., Webster R.G. DNA vaccine encoding hemagglutinin provides protective immunity against H5N1 influenza virus infection in mice. J Virol 1999, 73:2094-2098.
    • (1999) J Virol , vol.73 , pp. 2094-2098
    • Kodihalli, S.1    Goto, H.2    Kobasa, D.L.3    Krauss, S.4    Kawaoka, Y.5    Webster, R.G.6
  • 49
    • 79960369896 scopus 로고    scopus 로고
    • Complete protection against a H5N2 avian influenza virus by a DNA vaccine expressing a fusion protein of H1N1 HA and M2e
    • Park K.S., Seo Y.B., Lee J.Y., Im S.J., Seo S.H., Song M.S., et al. Complete protection against a H5N2 avian influenza virus by a DNA vaccine expressing a fusion protein of H1N1 HA and M2e. Vaccine 2011, 29:5481-5487.
    • (2011) Vaccine , vol.29 , pp. 5481-5487
    • Park, K.S.1    Seo, Y.B.2    Lee, J.Y.3    Im, S.J.4    Seo, S.H.5    Song, M.S.6
  • 50
    • 33847348999 scopus 로고    scopus 로고
    • Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1
    • Tompkins S.M., Zhao Z.S., Lo C.Y., Misplon J.A., Liu T., Ye Z., et al. Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1. Emerg Infect Dis 2007, 13:426-435.
    • (2007) Emerg Infect Dis , vol.13 , pp. 426-435
    • Tompkins, S.M.1    Zhao, Z.S.2    Lo, C.Y.3    Misplon, J.A.4    Liu, T.5    Ye, Z.6
  • 51
    • 84875854182 scopus 로고    scopus 로고
    • A polyvalent influenza A DNA vaccine induces heterologous immunity and protects pigs against pandemic A (H1N1) pdm09 virus infection
    • Bragstad K., Vinner L., Hansen M.S., Nielsen J., Fomsgaard A. A polyvalent influenza A DNA vaccine induces heterologous immunity and protects pigs against pandemic A (H1N1) pdm09 virus infection. Vaccine 2013, 31:2281-2288.
    • (2013) Vaccine , vol.31 , pp. 2281-2288
    • Bragstad, K.1    Vinner, L.2    Hansen, M.S.3    Nielsen, J.4    Fomsgaard, A.5
  • 52
    • 0037836033 scopus 로고    scopus 로고
    • Scaleable processes for the manufacture of therapeutic quantities of plasmid DNA
    • Shamlou P.A. Scaleable processes for the manufacture of therapeutic quantities of plasmid DNA. Biotechnol Appl Biochem 2003, 37:207-218.
    • (2003) Biotechnol Appl Biochem , vol.37 , pp. 207-218
    • Shamlou, P.A.1
  • 53
    • 0242710545 scopus 로고    scopus 로고
    • Industrial scale production of plasmid DNA for vaccine and gene therapy: plasmid design, production, and purification
    • Prather K.J., Sagar S., Murphy J., Chartrain M. Industrial scale production of plasmid DNA for vaccine and gene therapy: plasmid design, production, and purification. Enzyme Micro Technol 2003, 33:865-883.
    • (2003) Enzyme Micro Technol , vol.33 , pp. 865-883
    • Prather, K.J.1    Sagar, S.2    Murphy, J.3    Chartrain, M.4
  • 54
    • 28844490036 scopus 로고    scopus 로고
    • Bioprocess engineering issues that would be faced in producing a DNA vaccine at up to 100 m3 fermentation scale for an influenza pandemic
    • Hoare M., Levy M.S., Bracewell D.G., Doig S.D., Kong S., Titchener-Hooker N., et al. Bioprocess engineering issues that would be faced in producing a DNA vaccine at up to 100 m3 fermentation scale for an influenza pandemic. Biotechnol Prog 2005, 21:1577-1592.
    • (2005) Biotechnol Prog , vol.21 , pp. 1577-1592
    • Hoare, M.1    Levy, M.S.2    Bracewell, D.G.3    Doig, S.D.4    Kong, S.5    Titchener-Hooker, N.6
  • 55
    • 71049159517 scopus 로고    scopus 로고
    • Prospects for control of emerging infectious diseases withplasmid DNA vaccines
    • Moss R.B. Prospects for control of emerging infectious diseases withplasmid DNA vaccines. J Immune Based Ther Vaccines 2009, 7:3.
    • (2009) J Immune Based Ther Vaccines , vol.7 , pp. 3
    • Moss, R.B.1
  • 56
    • 0034691506 scopus 로고    scopus 로고
    • Triple transduction with adeno-associated virus vectors expressing tyrosine hydroxylase, aromatic-L-amino-acid decarboxylase, and GTP cyclohydrolase I for gene therapy of Parkinson's disease
    • Shen Y., Muramatsu S.I., Ikeguchi K., Fujimoto K.I., Fan D.S., Ogawa M., et al. Triple transduction with adeno-associated virus vectors expressing tyrosine hydroxylase, aromatic-L-amino-acid decarboxylase, and GTP cyclohydrolase I for gene therapy of Parkinson's disease. Hum Gene Ther 2000, 11:1509-1519.
    • (2000) Hum Gene Ther , vol.11 , pp. 1509-1519
    • Shen, Y.1    Muramatsu, S.I.2    Ikeguchi, K.3    Fujimoto, K.I.4    Fan, D.S.5    Ogawa, M.6
  • 58
    • 84884579421 scopus 로고    scopus 로고
    • Mucosal vaccination with recombinant adenovirus encoding nucleoprotein provides potent protection against influenza virus infection
    • Kim S.H., Kim J.Y., Choi Y., Nguyen H.H., Song M.K., Chang J. Mucosal vaccination with recombinant adenovirus encoding nucleoprotein provides potent protection against influenza virus infection. PloS One 2013, 8:e75460.
    • (2013) PloS One , vol.8 , pp. e75460
    • Kim, S.H.1    Kim, J.Y.2    Choi, Y.3    Nguyen, H.H.4    Song, M.K.5    Chang, J.6
  • 59
    • 84877344264 scopus 로고    scopus 로고
    • Single-dose vaccination of a recombinant parainfluenza virus 5 expressing NP from H5N1 virus provides broad immunity against influenza A viruses
    • Li Z., Gabbard J.D., Mooney A., Gao X., Chen Z., Place R.J., et al. Single-dose vaccination of a recombinant parainfluenza virus 5 expressing NP from H5N1 virus provides broad immunity against influenza A viruses. J Virol 2013, 87:5985-5993.
    • (2013) J Virol , vol.87 , pp. 5985-5993
    • Li, Z.1    Gabbard, J.D.2    Mooney, A.3    Gao, X.4    Chen, Z.5    Place, R.J.6
  • 60
    • 84876986696 scopus 로고    scopus 로고
    • Broadly protective adenovirus-based multivalent vaccines against highly pathogenic avian influenza viruses for pandemic preparedness
    • Vemula S.V., Ahi Y.S., Swaim A.M., Katz J.M., Donis R., Sambhara S., et al. Broadly protective adenovirus-based multivalent vaccines against highly pathogenic avian influenza viruses for pandemic preparedness. PloS One 2013, 8:e62496.
    • (2013) PloS One , vol.8 , pp. e62496
    • Vemula, S.V.1    Ahi, Y.S.2    Swaim, A.M.3    Katz, J.M.4    Donis, R.5    Sambhara, S.6
  • 61
    • 84921462503 scopus 로고    scopus 로고
    • Targeting the HA2 subunit of influenza A virus hemagglutinin via CD40L provides universal protection against diverse subtypes
    • Fan X., Hashem A.M., Chen Z., Li C., Doyle T., Zhang Y., et al. Targeting the HA2 subunit of influenza A virus hemagglutinin via CD40L provides universal protection against diverse subtypes. Mucosal Immunol 2015, 8:211-220.
    • (2015) Mucosal Immunol , vol.8 , pp. 211-220
    • Fan, X.1    Hashem, A.M.2    Chen, Z.3    Li, C.4    Doyle, T.5    Zhang, Y.6
  • 63
    • 0033858756 scopus 로고    scopus 로고
    • Influenza virus assembly: effect of influenza virus glycoproteins on the membrane association of M1 protein
    • Ali A., Avalos R.T., Ponimaskin E., Nayak D.P. Influenza virus assembly: effect of influenza virus glycoproteins on the membrane association of M1 protein. J Virol 2000, 74:8709-8719.
    • (2000) J Virol , vol.74 , pp. 8709-8719
    • Ali, A.1    Avalos, R.T.2    Ponimaskin, E.3    Nayak, D.P.4
  • 64
    • 7244261639 scopus 로고    scopus 로고
    • Highly efficient and economical baculovirus expression system for preparing human papillomavirus type16 virus-like particle
    • Zheng J., Ma J., Yang X.F., Liu H.L., Cheng H.W., Si L.S., et al. Highly efficient and economical baculovirus expression system for preparing human papillomavirus type16 virus-like particle. Acta Biochim Biophy Sin (Shanghai) 2004, 36:548-552.
    • (2004) Acta Biochim Biophy Sin (Shanghai) , vol.36 , pp. 548-552
    • Zheng, J.1    Ma, J.2    Yang, X.F.3    Liu, H.L.4    Cheng, H.W.5    Si, L.S.6
  • 65
    • 0027240069 scopus 로고
    • Comparison of the reactivities of baculovirus-expressed recombinant Norwalk virus capsid antigen with those of the native Norwalk virus antigen in serologic assays and some epidemiologic observations
    • Green K., Lew J., Jiang X., Kapikian A., Estes M. Comparison of the reactivities of baculovirus-expressed recombinant Norwalk virus capsid antigen with those of the native Norwalk virus antigen in serologic assays and some epidemiologic observations. J Clin Microbiol 1993, 31:2185-2191.
    • (1993) J Clin Microbiol , vol.31 , pp. 2185-2191
    • Green, K.1    Lew, J.2    Jiang, X.3    Kapikian, A.4    Estes, M.5
  • 66
    • 77951297002 scopus 로고    scopus 로고
    • Reverse micelle-encapsulated recombinant baculovirus as an oral vaccine against H5N1 infection in mice
    • Prabakaran M., Madhan S., Prabhu N., Geng G.Y., New R., Kwang J. Reverse micelle-encapsulated recombinant baculovirus as an oral vaccine against H5N1 infection in mice. Antivir Res 2010, 86:180-187.
    • (2010) Antivir Res , vol.86 , pp. 180-187
    • Prabakaran, M.1    Madhan, S.2    Prabhu, N.3    Geng, G.Y.4    New, R.5    Kwang, J.6
  • 68
    • 0023820458 scopus 로고
    • Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions
    • Zebedee S.L., Lamb R.A. Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions. J Virol 1988, 62:2762-2772.
    • (1988) J Virol , vol.62 , pp. 2762-2772
    • Zebedee, S.L.1    Lamb, R.A.2
  • 70
    • 84860407785 scopus 로고    scopus 로고
    • Vaccination with different M2e epitope densities confers partial protection against H5N1 influenza A virus challenge in chickens
    • Zhang X., Liu M., Liu C., Du J., Shi W., Sun E., et al. Vaccination with different M2e epitope densities confers partial protection against H5N1 influenza A virus challenge in chickens. Intervirology 2011, 54:290-299.
    • (2011) Intervirology , vol.54 , pp. 290-299
    • Zhang, X.1    Liu, M.2    Liu, C.3    Du, J.4    Shi, W.5    Sun, E.6
  • 71
    • 84880029888 scopus 로고    scopus 로고
    • An M2e-based synthetic peptide vaccine for influenza A virus confers heterosubtypic protection from lethal virus challenge
    • Ma J.H., Yang F.R., Yu H., Zhou Y.J., Li G.X., Huang M., et al. An M2e-based synthetic peptide vaccine for influenza A virus confers heterosubtypic protection from lethal virus challenge. Virol J 2013, 10:227.
    • (2013) Virol J , vol.10 , pp. 227
    • Ma, J.H.1    Yang, F.R.2    Yu, H.3    Zhou, Y.J.4    Li, G.X.5    Huang, M.6
  • 72
    • 77954409486 scopus 로고    scopus 로고
    • An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus
    • Zhao G., Sun S., Du L., Xiao W., Ru Z., Kou Z., et al. An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus. Virol J 2010, 7:151.
    • (2010) Virol J , vol.7 , pp. 151
    • Zhao, G.1    Sun, S.2    Du, L.3    Xiao, W.4    Ru, Z.5    Kou, Z.6
  • 73
    • 77249104563 scopus 로고    scopus 로고
    • An M2e-based multiple antigenic peptide vaccine protects mice from lethal challenge with divergent H5N1 influenza viruses
    • Zhao G., Lin Y., Du L., Guan J., Sun S., Sui H., et al. An M2e-based multiple antigenic peptide vaccine protects mice from lethal challenge with divergent H5N1 influenza viruses. Virol J 2010, 7:9.
    • (2010) Virol J , vol.7 , pp. 9
    • Zhao, G.1    Lin, Y.2    Du, L.3    Guan, J.4    Sun, S.5    Sui, H.6
  • 74
    • 84861823634 scopus 로고    scopus 로고
    • In contrast to conventional inactivated influenza vaccines, 4xM2e. HSP70c fusion protein fully protected mice against lethal dose of H1, H3 and H9 influenza A isolates circulating in Iran
    • Ebrahimi S.M., Dabaghian M., Tebianian M., Zabeh Jazi M.H. In contrast to conventional inactivated influenza vaccines, 4xM2e. HSP70c fusion protein fully protected mice against lethal dose of H1, H3 and H9 influenza A isolates circulating in Iran. Virology 2012, 430:63-72.
    • (2012) Virology , vol.430 , pp. 63-72
    • Ebrahimi, S.M.1    Dabaghian, M.2    Tebianian, M.3    Zabeh Jazi, M.H.4
  • 75
    • 84872619128 scopus 로고    scopus 로고
    • Tandem repeats of the extracellular domain of Matrix 2 influenza protein exposed in Brucella lumazine synthase decameric carrier molecule induce protection in mice
    • Alvarez P., Zylberman V., Ghersi G., Boado L., Palacios C., Goldbaum F., et al. Tandem repeats of the extracellular domain of Matrix 2 influenza protein exposed in Brucella lumazine synthase decameric carrier molecule induce protection in mice. Vaccine 2013, 31:806-812.
    • (2013) Vaccine , vol.31 , pp. 806-812
    • Alvarez, P.1    Zylberman, V.2    Ghersi, G.3    Boado, L.4    Palacios, C.5    Goldbaum, F.6
  • 76
    • 77957821697 scopus 로고    scopus 로고
    • Induction of protection against divergent H5N1 influenza viruses using a recombinant fusion protein linking influenza M2e to Onchocerca volvulus activation associated protein-1 (ASP-1) adjuvant
    • Zhao G., Du L., Xiao W., Sun S., Lin Y., Chen M., et al. Induction of protection against divergent H5N1 influenza viruses using a recombinant fusion protein linking influenza M2e to Onchocerca volvulus activation associated protein-1 (ASP-1) adjuvant. Vaccine 2010, 28:7233-7240.
    • (2010) Vaccine , vol.28 , pp. 7233-7240
    • Zhao, G.1    Du, L.2    Xiao, W.3    Sun, S.4    Lin, Y.5    Chen, M.6
  • 77
    • 65449185906 scopus 로고    scopus 로고
    • Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments
    • Schotsaert M., De Filette M., Fiers W., Saelens X. Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments. Expert Rev Vaccines 2009, 8:499-508.
    • (2009) Expert Rev Vaccines , vol.8 , pp. 499-508
    • Schotsaert, M.1    De Filette, M.2    Fiers, W.3    Saelens, X.4
  • 78
    • 40749139110 scopus 로고    scopus 로고
    • Healthy human subjects have CD4+ T cells directed against H5N1 influenza virus
    • Roti M., Yang J., Berger D., Huston L., James E.A., Kwok W.W. Healthy human subjects have CD4+ T cells directed against H5N1 influenza virus. J Immunol 2008, 180:1758-1768.
    • (2008) J Immunol , vol.180 , pp. 1758-1768
    • Roti, M.1    Yang, J.2    Berger, D.3    Huston, L.4    James, E.A.5    Kwok, W.W.6
  • 79
    • 84876178716 scopus 로고    scopus 로고
    • Influenza nucleoprotein delivered with aluminium salts protects mice from an influenza A virus that expresses an altered nucleoprotein sequence
    • MacLeod M.K., David A., Jin N., Noges L., Wang J., Kappler J.W., et al. Influenza nucleoprotein delivered with aluminium salts protects mice from an influenza A virus that expresses an altered nucleoprotein sequence. PloS One 2013, 8:e61775.
    • (2013) PloS One , vol.8 , pp. e61775
    • MacLeod, M.K.1    David, A.2    Jin, N.3    Noges, L.4    Wang, J.5    Kappler, J.W.6
  • 80
    • 23844520881 scopus 로고    scopus 로고
    • Functional constraints of influenza A virus epitopes limit escape from cytotoxic T lymphocytes
    • Berkhoff E., De Wit E., Geelhoed-Mieras M., Boon A., Symons J., Fouchier R., et al. Functional constraints of influenza A virus epitopes limit escape from cytotoxic T lymphocytes. J Virol 2005, 79:11239-11246.
    • (2005) J Virol , vol.79 , pp. 11239-11246
    • Berkhoff, E.1    De Wit, E.2    Geelhoed-Mieras, M.3    Boon, A.4    Symons, J.5    Fouchier, R.6
  • 82
    • 84897110525 scopus 로고    scopus 로고
    • Safety and immunogenicity of a plant-produced recombinant monomer hemagglutinin-based influenza vaccine derived from influenza A (H1N1) pdm09 virus: a Phase 1 dose-escalation study in healthy adults
    • Cummings J.F., Guerrero M.L., Moon J.E., Waterman P., Nielsen R.K., Jefferson S., et al. Safety and immunogenicity of a plant-produced recombinant monomer hemagglutinin-based influenza vaccine derived from influenza A (H1N1) pdm09 virus: a Phase 1 dose-escalation study in healthy adults. Vaccine 2014, 32:2251-2259.
    • (2014) Vaccine , vol.32 , pp. 2251-2259
    • Cummings, J.F.1    Guerrero, M.L.2    Moon, J.E.3    Waterman, P.4    Nielsen, R.K.5    Jefferson, S.6
  • 83
    • 84886089846 scopus 로고    scopus 로고
    • A subunit vaccine candidate derived from a classic H5N1 avian influenza virus in China protects fowls and BALB/c mice from lethal challenge
    • Liu G., Zhang F., Shi J., Tian G., Chen H., Yu K., et al. A subunit vaccine candidate derived from a classic H5N1 avian influenza virus in China protects fowls and BALB/c mice from lethal challenge. Vaccine 2013, 31:5398-5404.
    • (2013) Vaccine , vol.31 , pp. 5398-5404
    • Liu, G.1    Zhang, F.2    Shi, J.3    Tian, G.4    Chen, H.5    Yu, K.6
  • 84
    • 84899892665 scopus 로고    scopus 로고
    • Glycan masking of hemagglutinin for adenovirus vector and recombinant protein immunizations elicits broadly neutralizing antibodies against H5N1 avian influenza viruses
    • Lin S.C., Liu W.C., Jan J.T., Wu S.C. Glycan masking of hemagglutinin for adenovirus vector and recombinant protein immunizations elicits broadly neutralizing antibodies against H5N1 avian influenza viruses. PloS One 2014, 9:e92822.
    • (2014) PloS One , vol.9 , pp. e92822
    • Lin, S.C.1    Liu, W.C.2    Jan, J.T.3    Wu, S.C.4
  • 85
    • 79551557170 scopus 로고    scopus 로고
    • A recombinant vaccine of H5N1 HA1 fused with foldon and human IgG Fc induced complete cross-clade protection against divergent H5N1 viruses
    • Du L., Zhang X., Zhou J., Chen M., He W., Zhang H.Y., et al. A recombinant vaccine of H5N1 HA1 fused with foldon and human IgG Fc induced complete cross-clade protection against divergent H5N1 viruses. PloS One 2011, 6:e16555.
    • (2011) PloS One , vol.6 , pp. e16555
    • Du, L.1    Zhang, X.2    Zhou, J.3    Chen, M.4    He, W.5    Zhang, H.Y.6
  • 86
    • 84872190107 scopus 로고    scopus 로고
    • A critical HA1 neutralizing domain of H5N1 influenza in an optimal conformation induces strong cross-protection
    • Du L., Zhao G., Sun S., Zhang X., Zhou X., Guo Y., et al. A critical HA1 neutralizing domain of H5N1 influenza in an optimal conformation induces strong cross-protection. PloS One 2013, 8:e53568.
    • (2013) PloS One , vol.8 , pp. e53568
    • Du, L.1    Zhao, G.2    Sun, S.3    Zhang, X.4    Zhou, X.5    Guo, Y.6
  • 87
    • 84902166999 scopus 로고    scopus 로고
    • Protective immunity based on the conserved hemagglutinin stalk domain and its prospects for universal influenza vaccine development
    • Khanna M., Sharma S., Kumar B., Rajput R. Protective immunity based on the conserved hemagglutinin stalk domain and its prospects for universal influenza vaccine development. Biomed Res Int 2014, 2014:546274.
    • (2014) Biomed Res Int , vol.2014 , pp. 546274
    • Khanna, M.1    Sharma, S.2    Kumar, B.3    Rajput, R.4
  • 88
    • 78649953803 scopus 로고    scopus 로고
    • Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes
    • Wang T.T., Tan G.S., Hai R., Pica N., Ngai L., Ekiert D.C., et al. Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes. Proc Natl Acad Sci U S A 2010, 107:18979-18984.
    • (2010) Proc Natl Acad Sci U S A , vol.107 , pp. 18979-18984
    • Wang, T.T.1    Tan, G.S.2    Hai, R.3    Pica, N.4    Ngai, L.5    Ekiert, D.C.6
  • 89
    • 77956379133 scopus 로고    scopus 로고
    • Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge
    • Bommakanti G., Citron M.P., Hepler R.W., Callahan C., Heidecker G.J., Najar T.A., et al. Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge. Proc Natl Acad Sci U S A 2010, 107:13701-13706.
    • (2010) Proc Natl Acad Sci U S A , vol.107 , pp. 13701-13706
    • Bommakanti, G.1    Citron, M.P.2    Hepler, R.W.3    Callahan, C.4    Heidecker, G.J.5    Najar, T.A.6
  • 90
    • 78249285928 scopus 로고    scopus 로고
    • Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant
    • Sui Z., Chen Q., Fang F., Zheng M., Chen Z. Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant. Vaccine 2010, 28:7690-7698.
    • (2010) Vaccine , vol.28 , pp. 7690-7698
    • Sui, Z.1    Chen, Q.2    Fang, F.3    Zheng, M.4    Chen, Z.5
  • 91
    • 71849116990 scopus 로고    scopus 로고
    • Influenza neuraminidase as a vaccine antigen
    • Sylte M.J., Suarez D.L. Influenza neuraminidase as a vaccine antigen. Curr Top Microbiol Immunol 2009, 333:227-241.
    • (2009) Curr Top Microbiol Immunol , vol.333 , pp. 227-241
    • Sylte, M.J.1    Suarez, D.L.2
  • 92
    • 84895448120 scopus 로고    scopus 로고
    • Evaluation of the antigenic relatedness and cross-protective immunity of the neuraminidase between human influenza A (H1N1) virus and highly pathogenic avian influenza A (H5N1) virus
    • Lu X., Liu F., Zeng H., Sheu T., Achenbach J.E., Veguilla V., et al. Evaluation of the antigenic relatedness and cross-protective immunity of the neuraminidase between human influenza A (H1N1) virus and highly pathogenic avian influenza A (H5N1) virus. Virology 2014, 454:169-175.
    • (2014) Virology , vol.454 , pp. 169-175
    • Lu, X.1    Liu, F.2    Zeng, H.3    Sheu, T.4    Achenbach, J.E.5    Veguilla, V.6
  • 93
  • 94
    • 84874698540 scopus 로고    scopus 로고
    • Neuraminidase-inhibiting antibody is a correlate of cross-protection against lethal H5N1 influenza virus in ferrets immunized with seasonal influenza vaccine
    • Rockman S., Brown L.E., Barr I.G., Gilbertson B., Lowther S., Kachurin A., et al. Neuraminidase-inhibiting antibody is a correlate of cross-protection against lethal H5N1 influenza virus in ferrets immunized with seasonal influenza vaccine. J Virol 2013, 87:3053-3061.
    • (2013) J Virol , vol.87 , pp. 3053-3061
    • Rockman, S.1    Brown, L.E.2    Barr, I.G.3    Gilbertson, B.4    Lowther, S.5    Kachurin, A.6
  • 95
    • 84871284434 scopus 로고    scopus 로고
    • Enhancement of the immunogenicity and protective efficacy of a mucosal influenza subunit vaccine by the saponin adjuvant GPI-0100
    • Liu H., Patil H.P., de Vries-Idema J., Wilschut J., Huckriede A. Enhancement of the immunogenicity and protective efficacy of a mucosal influenza subunit vaccine by the saponin adjuvant GPI-0100. PloS One 2012, 7:e52135.
    • (2012) PloS One , vol.7 , pp. e52135
    • Liu, H.1    Patil, H.P.2    de Vries-Idema, J.3    Wilschut, J.4    Huckriede, A.5
  • 96
    • 53449091640 scopus 로고    scopus 로고
    • Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant
    • Prabakaran M., Velumani S., He F., Karuppannan A.K., Geng G.Y., Yin L.K., et al. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant. Virology 2008, 380:412-420.
    • (2008) Virology , vol.380 , pp. 412-420
    • Prabakaran, M.1    Velumani, S.2    He, F.3    Karuppannan, A.K.4    Geng, G.Y.5    Yin, L.K.6
  • 98
    • 37449031125 scopus 로고    scopus 로고
    • Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin
    • Huleatt J.W., Nakaar V., Desai P., Huang Y., Hewitt D., Jacobs A., et al. Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin. Vaccine 2008, 26:201-214.
    • (2008) Vaccine , vol.26 , pp. 201-214
    • Huleatt, J.W.1    Nakaar, V.2    Desai, P.3    Huang, Y.4    Hewitt, D.5    Jacobs, A.6
  • 99
    • 84884577550 scopus 로고    scopus 로고
    • Immunogenicity and protective efficacy of a dual subunit vaccine against respiratory syncytial virus and influenza virus
    • Park M.H., Chang J. Immunogenicity and protective efficacy of a dual subunit vaccine against respiratory syncytial virus and influenza virus. Immune Netw 2012, 12:261-268.
    • (2012) Immune Netw , vol.12 , pp. 261-268
    • Park, M.H.1    Chang, J.2
  • 100
    • 84897531848 scopus 로고    scopus 로고
    • Sublingual immunization with a subunit influenza vaccine elicits comparable systemic immune response as intramuscular immunization, but also induces local IgA and TH17 responses
    • Gallorini S., Taccone M., Bonci A., Nardelli F., Casini D., Bonificio A., et al. Sublingual immunization with a subunit influenza vaccine elicits comparable systemic immune response as intramuscular immunization, but also induces local IgA and TH17 responses. Vaccine 2014, 32:2382-2388.
    • (2014) Vaccine , vol.32 , pp. 2382-2388
    • Gallorini, S.1    Taccone, M.2    Bonci, A.3    Nardelli, F.4    Casini, D.5    Bonificio, A.6
  • 101
    • 84881163364 scopus 로고    scopus 로고
    • Evaluation of mucosal and systemic immune responses elicited by GPI-0100-adjuvanted influenza vaccine delivered by different immunization strategies
    • Liu H., Patil H.P., de Vries-Idema J., Wilschut J., Huckriede A. Evaluation of mucosal and systemic immune responses elicited by GPI-0100-adjuvanted influenza vaccine delivered by different immunization strategies. PloS One 2013, 8:e69649.
    • (2013) PloS One , vol.8 , pp. e69649
    • Liu, H.1    Patil, H.P.2    de Vries-Idema, J.3    Wilschut, J.4    Huckriede, A.5
  • 102
    • 84869871946 scopus 로고    scopus 로고
    • Induction of cross-protection against influenza A virus by DNA prime-intranasal protein boost strategy based on nucleoprotein
    • Luo J., Zheng D., Zhang W., Fang F., Wang H., Sun Y., et al. Induction of cross-protection against influenza A virus by DNA prime-intranasal protein boost strategy based on nucleoprotein. Virol J 2012, 9:286.
    • (2012) Virol J , vol.9 , pp. 286
    • Luo, J.1    Zheng, D.2    Zhang, W.3    Fang, F.4    Wang, H.5    Sun, Y.6
  • 103
    • 84903788950 scopus 로고    scopus 로고
    • Supplementation of influenza split vaccines with conserved M2 ectodomains overcomes strain specificity and provides long-term cross protection
    • Kim M.C., Lee Y.N., Ko E.J., Lee J.S., Kwon Y.M., Hwang H.S., et al. Supplementation of influenza split vaccines with conserved M2 ectodomains overcomes strain specificity and provides long-term cross protection. Mol Ther 2014, 22:1364-1374.
    • (2014) Mol Ther , vol.22 , pp. 1364-1374
    • Kim, M.C.1    Lee, Y.N.2    Ko, E.J.3    Lee, J.S.4    Kwon, Y.M.5    Hwang, H.S.6
  • 104
    • 84875668090 scopus 로고    scopus 로고
    • Prokaryote-expressed M2e protein improves H9N2 influenza vaccine efficacy and protection against lethal influenza a virus in mice
    • Kim E.H., Lee J.H., Pascua P., Song M.S., Baek Y.H., Kwon H., et al. Prokaryote-expressed M2e protein improves H9N2 influenza vaccine efficacy and protection against lethal influenza a virus in mice. Virol J 2013, 10:104.
    • (2013) Virol J , vol.10 , pp. 104
    • Kim, E.H.1    Lee, J.H.2    Pascua, P.3    Song, M.S.4    Baek, Y.H.5    Kwon, H.6
  • 106
    • 68349148002 scopus 로고    scopus 로고
    • Immunization of chickens with Newcastle disease virus expressing H5 hemagglutinin protects against highly pathogenic H5N1 avian influenza viruses
    • Nayak B., Rout S.N., Kumar S., Khalil M.S., Fouda M.M., Ahmed L.E., et al. Immunization of chickens with Newcastle disease virus expressing H5 hemagglutinin protects against highly pathogenic H5N1 avian influenza viruses. PLoS One 2009, 4:e6509.
    • (2009) PLoS One , vol.4 , pp. e6509
    • Nayak, B.1    Rout, S.N.2    Kumar, S.3    Khalil, M.S.4    Fouda, M.M.5    Ahmed, L.E.6
  • 107
    • 84897542803 scopus 로고    scopus 로고
    • Immunogenicity and efficacy of a recombinant adenovirus expressing hemagglutinin from the H5N1 subtype of swine influenza virus in mice
    • Wu Y., Qiao C., Yang H., Chen Y., Xin X., Chen H. Immunogenicity and efficacy of a recombinant adenovirus expressing hemagglutinin from the H5N1 subtype of swine influenza virus in mice. Can J Vet Res 2014, 78:117-126.
    • (2014) Can J Vet Res , vol.78 , pp. 117-126
    • Wu, Y.1    Qiao, C.2    Yang, H.3    Chen, Y.4    Xin, X.5    Chen, H.6
  • 108
    • 84907704195 scopus 로고    scopus 로고
    • Immunogenicity of avian influenza A/Anhui/01/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trial
    • Belshe R.B., Frey S.E., Graham I.L., Anderson E.L., Jackson L.A., Spearman P., et al. Immunogenicity of avian influenza A/Anhui/01/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trial. J Am Mes Assoc 2014, 312:1420-1428.
    • (2014) J Am Mes Assoc , vol.312 , pp. 1420-1428
    • Belshe, R.B.1    Frey, S.E.2    Graham, I.L.3    Anderson, E.L.4    Jackson, L.A.5    Spearman, P.6
  • 109
  • 110
    • 84939621841 scopus 로고    scopus 로고
    • AS03B-adjuvanted H5N1 influenza vaccine in children 6 months through 17 years of age: a phase 2/3 randomized, placebo-controlled, observer-blinded trial
    • pii: jiu548
    • Kosalaraksa P., Jeanfreau R., Frenette L., Drame M., Madariaga M., Innis B.L., et al. AS03B-adjuvanted H5N1 influenza vaccine in children 6 months through 17 years of age: a phase 2/3 randomized, placebo-controlled, observer-blinded trial. J Infect Dis 2014, pii: jiu548.
    • (2014) J Infect Dis
    • Kosalaraksa, P.1    Jeanfreau, R.2    Frenette, L.3    Drame, M.4    Madariaga, M.5    Innis, B.L.6
  • 111
    • 84907698232 scopus 로고    scopus 로고
    • Serological responses to an avian influenza A/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant: a randomized clinical trial
    • Mulligan M.J., Bernstein D.I., Winokur P., Rupp R., Anderson E., Rouphael N., et al. Serological responses to an avian influenza A/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant: a randomized clinical trial. J Am Med Assoc 2014, 312:1409-1419.
    • (2014) J Am Med Assoc , vol.312 , pp. 1409-1419
    • Mulligan, M.J.1    Bernstein, D.I.2    Winokur, P.3    Rupp, R.4    Anderson, E.5    Rouphael, N.6
  • 112
    • 79951645476 scopus 로고    scopus 로고
    • Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1
    • Berthoud T.K., Hamill M., Lillie P.J., Hwenda L., Collins K.A., Ewer K.J., et al. Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1. Clin Infect Dis 2011, 52:1-7.
    • (2011) Clin Infect Dis , vol.52 , pp. 1-7
    • Berthoud, T.K.1    Hamill, M.2    Lillie, P.J.3    Hwenda, L.4    Collins, K.A.5    Ewer, K.J.6
  • 113
    • 84921462712 scopus 로고    scopus 로고
    • Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine: a randomised, double-blind phase 1/2a clinical trial
    • Kreijtz J.H., Goeijenbier M., Moesker F.M., van den Dries L., Goeijenbier S., De Gruyter H.L., et al. Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine: a randomised, double-blind phase 1/2a clinical trial. Lancet Infect Dis 2014, 14:1196-1207.
    • (2014) Lancet Infect Dis , vol.14 , pp. 1196-1207
    • Kreijtz, J.H.1    Goeijenbier, M.2    Moesker, F.M.3    van den Dries, L.4    Goeijenbier, S.5    De Gruyter, H.L.6
  • 114
    • 84870622077 scopus 로고    scopus 로고
    • Safety and immunogenicity of a plant-produced recombinant hemagglutinin-based influenza vaccine (HAI-05) derived from A/Indonesia/05/2005 (H5N1) influenza virus: a phase 1 randomized, double-blind, placebo-controlled, dose-escalation study in healthy adults
    • Chichester J.A., Jones R.M., Green B.J., Stow M., Miao F., Moonsammy G., et al. Safety and immunogenicity of a plant-produced recombinant hemagglutinin-based influenza vaccine (HAI-05) derived from A/Indonesia/05/2005 (H5N1) influenza virus: a phase 1 randomized, double-blind, placebo-controlled, dose-escalation study in healthy adults. Viruses 2012, 4:3227-3244.
    • (2012) Viruses , vol.4 , pp. 3227-3244
    • Chichester, J.A.1    Jones, R.M.2    Green, B.J.3    Stow, M.4    Miao, F.5    Moonsammy, G.6
  • 116
    • 84869085329 scopus 로고    scopus 로고
    • Autoimmune disorders after immunisation with influenza A/H1N1 vaccines with and without adjuvant: EudraVigilance data and literature review
    • Isai A., Durand J., Le Meur S., Hidalgo-Simon A., Kurz X. Autoimmune disorders after immunisation with influenza A/H1N1 vaccines with and without adjuvant: EudraVigilance data and literature review. Vaccine 2012, 30:7123-7129.
    • (2012) Vaccine , vol.30 , pp. 7123-7129
    • Isai, A.1    Durand, J.2    Le Meur, S.3    Hidalgo-Simon, A.4    Kurz, X.5
  • 118
    • 84922335468 scopus 로고    scopus 로고
    • Technology transfer and scale-up of the Flublok recombinant hemagglutinin (HA) influenza vaccine manufacturing process
    • Buckland B., Boulanger R., Fino M., Srivastava I., Holtz K., Khramtsov N., et al. Technology transfer and scale-up of the Flublok recombinant hemagglutinin (HA) influenza vaccine manufacturing process. Vaccine 2014, 32:5496-5502.
    • (2014) Vaccine , vol.32 , pp. 5496-5502
    • Buckland, B.1    Boulanger, R.2    Fino, M.3    Srivastava, I.4    Holtz, K.5    Khramtsov, N.6
  • 119
    • 79751471067 scopus 로고    scopus 로고
    • Safety and immunogenicity of influenza A H5 subunit vaccines: effect of vaccine schedule and antigenic variant
    • Belshe R.B., Frey S.E., Graham I., Mulligan M.J., Edupuganti S., Jackson L.A., et al. Safety and immunogenicity of influenza A H5 subunit vaccines: effect of vaccine schedule and antigenic variant. J Infect Dis 2011, 203:666-673.
    • (2011) J Infect Dis , vol.203 , pp. 666-673
    • Belshe, R.B.1    Frey, S.E.2    Graham, I.3    Mulligan, M.J.4    Edupuganti, S.5    Jackson, L.A.6
  • 120
    • 84920604106 scopus 로고    scopus 로고
    • Immunogenicity of heterologous H5N1 influenza booster vaccination 6 or 18 months after primary vaccination in adults: a randomized controlled clinical trial
    • Langley J.M., Frenette L., Jeanfreau R., Halperin S.A., Kyle M., Chu L., et al. Immunogenicity of heterologous H5N1 influenza booster vaccination 6 or 18 months after primary vaccination in adults: a randomized controlled clinical trial. Vaccine 2014, 10.1016/j.vaccine.2014.11.018.
    • (2014) Vaccine
    • Langley, J.M.1    Frenette, L.2    Jeanfreau, R.3    Halperin, S.A.4    Kyle, M.5    Chu, L.6
  • 121
    • 84906080801 scopus 로고    scopus 로고
    • Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine: results from a double-blinded, randomized phase I clinical trial in healthy Asian volunteers
    • Low J.G., Lee L.S., Ooi E.E., Ethirajulu K., Yeo P., Matter A., et al. Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine: results from a double-blinded, randomized phase I clinical trial in healthy Asian volunteers. Vaccine 2014, 32:5041-5048.
    • (2014) Vaccine , vol.32 , pp. 5041-5048
    • Low, J.G.1    Lee, L.S.2    Ooi, E.E.3    Ethirajulu, K.4    Yeo, P.5    Matter, A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.